1996
DOI: 10.1097/00007890-199612270-00045
|View full text |Cite
|
Sign up to set email alerts
|

Decreased Urinary Excretion of Nitric Oxide in Acute Rejection Episodes in Pediatric Renal Allograft Recipients1

Abstract: Acute renal allograft rejection continues to have a negative effect on graft survival despite a better understanding of the molecular basis of renal allograft rejection. Nitric oxide (NO) has important biological functions in cell defense and injury and some evidence exists that it may act as an immunomodulator in allograft transplantation. To determine if NO has any role in acute renal allograft rejection in pediatric patients, acute rejection episodes in pediatric renal transplant recipients were evaluated. … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
13
0
1

Year Published

2001
2001
2012
2012

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 15 publications
(14 citation statements)
references
References 12 publications
0
13
0
1
Order By: Relevance
“…In humans, conflicting data on NO x levels in both serum and urine have been found in acute renal allograft rejection (15)(16)(17)(18). Using immunohistochemistry, we recently found an increase in interstitial and glomerular iNOS expression and a decrease in glomerular eNOS expression in patients with AR compared with control kidneys (17).…”
mentioning
confidence: 93%
“…In humans, conflicting data on NO x levels in both serum and urine have been found in acute renal allograft rejection (15)(16)(17)(18). Using immunohistochemistry, we recently found an increase in interstitial and glomerular iNOS expression and a decrease in glomerular eNOS expression in patients with AR compared with control kidneys (17).…”
mentioning
confidence: 93%
“…3,4 There are reports about the role of NO in I/R and allograft rejection in liver, heart, kidney, and pancreatic islet cell transplant. [21][22][23][24][25][26][27] Inhaled NO or NO donor drugs are novel treatments that have been used clinically to diminish I/R.…”
Section: Discussionmentioning
confidence: 99%
“…Recently, most metabolomic studies were focused on kidney transplantation to assess biomarkers associated with posttransplantation function, renal dysfunction, acute rejection and subclinical rejection [1,9,10,11,12,13,14,15,16,17] and others on liver and heart transplantation [18,19,20,21] to identify prognostic and diagnostic markers of organ rejection and dysfunction [22,23,24]. This is the first time that the metabonomics technique has been applied to human intestinal transplantation.…”
Section: Discussionmentioning
confidence: 99%